Open access · OA
via OpenAlex
Genetics of age-related macular degeneration (AMD)
Margaret M. DeAngelis, Leah A. Owen, Margaux A. Morrison, Denise J. Morgan, Mingyao Li, Akbar Shakoor, Albert T. Vitale, Sudha K. Iyengar, Dwight Stambolian, Ivana K. Kim, Lindsay A. Farrer
Human Molecular Genetics · 2017 · ▲ 164 citations
Abstract
Age-related macular degeneration (AMD) is a progressive blinding disease and represents the leading cause of visual impairment in the aging population. AMD affects central vision which impairs one's ability to drive, read and recognize faces. There is no cure for this disease and current treatment modalities for the exudative form of the disease require repeated intravitreal injections which may be painful, are incompletely efficacious, and represent a significant treatment burden for both the patient and physician. As such, AMD represents a significant and important clinical problem.It is anticipated that in three years' time, 196 million individuals will be affected with AMD. Over 250 billion dollars per year are spent on care for AMD patients in the US. Over half of the heritability is explained by two major loci, thus AMD is considered the most well genetically defined of the complex disorders. A recent GWAS on 43,566 subjects identified novel loci and pathways associated with AMD risk, which has provided an excellent platform for additional functional studies. Genetic variants have been investigated, particularly with respect to anti-VEGF treatment, however to date, no pharmacogenomic associations have been consistently identified across these studies. It may be that if the goal of personalized medicine is to be realized and biomarkers are to have predictive value for determining the magnitude of risk for AMD at the genetic level, one will need to examine the relationships between these pathways across disease state and relative to modifiable risk factors such as hypertension, smoking, body mass index, and hypercholesterolemia. Further studies investigating protective alleles in populations with low AMD prevalence may lead to this goal.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/hmg/ddx228
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
DeAngelis, M.M., Owen, L.A., Morrison, M.A., Morgan, D.J., Li, M., Shakoor, A., Vitale, A.T., Iyengar, S.K., Stambolian, D., Kim, I.K., & Farrer, L.A. (2017). Genetics of age-related macular degeneration (AMD). <em>Human Molecular Genetics</em>. https://doi.org/10.1093/hmg/ddx228
Vancouver
DeAngelis MM, Owen LA, Morrison MA, Morgan DJ, Li M, Shakoor A, et al. Genetics of age-related macular degeneration (AMD). Human Molecular Genetics. 2017. doi:10.1093/hmg/ddx228.
BibTeX
@article{margaret2017Geneti,
title = {Genetics of age-related macular degeneration (AMD)},
author = {Margaret M. DeAngelis and Leah A. Owen and Margaux A. Morrison and Denise J. Morgan and Mingyao Li and Akbar Shakoor and Albert T. Vitale and Sudha K. Iyengar and Dwight Stambolian and Ivana K. Kim and Lindsay A. Farrer},
journal = {Human Molecular Genetics},
year = {2017},
doi = {10.1093/hmg/ddx228},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Genetics 2013
Open access · CC-BY
Age‐related macular degeneration—clinical review and genetics update
Science 1997
Citation only
Mutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular Degeneration
Annals of Medicine 2006
Open access · OA
Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts
PLoS ONE 2012
Open access · CC-BY
Modelling the Genetic Risk in Age-Related Macular Degeneration
Seminars in Ophthalmology 2007
Citation only
Review of Genetics in Age Related Macular Degeneration
Clinical Interventions in Aging 2017
Open access · CC-BY